Literature DB >> 12105351

UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine.

Viti Kothari1, Richard J Stevens, Amanda I Adler, Irene M Stratton, Susan E Manley, H Andrew Neil, Rudy R Holman.   

Abstract

BACKGROUND AND
PURPOSE: People with type 2 diabetes are at elevated risk of stroke compared with those without diabetes. Relative risks have been examined in earlier work, but there is no readily available method for predicting the absolute risk of stroke in a diabetic individual. We developed mathematical models to estimate the risk of a first stroke using data from 4549 newly diagnosed type 2 diabetic patients enrolled in the UK Prospective Diabetes Study.
METHODS: During 30 700 person-years of follow-up, 188 first strokes (52 fatal) occurred. Model fitting was carried out by maximum likelihood estimation using the Newton-Raphson method. Diagnostic plots were used to compare survival probabilities calculated by the model with those calculated using nonparametric methods.
RESULTS: Variables included in the final model were duration of diabetes, age, sex, smoking, systolic blood pressure, total cholesterol to high-density lipoprotein cholesterol ratio and presence of atrial fibrillation. Not included in the model were body mass index, hemoglobin A1c, ethnicity, and ex-smoking status. The use of the model is illustrated with a hypothetical study power calculation.
CONCLUSIONS: This model forecasts the absolute risk of a first stroke in people with type 2 diabetes using variables readily available in routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105351     DOI: 10.1161/01.str.0000020091.07144.c7

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  125 in total

1.  Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study.

Authors:  D R Webb; L J Gray; K Khunti; B Srinivasan; N Taub; S Campbell; J Barnett; A Farooqi; J B Echouffo-Tcheugui; S J Griffin; N J Wareham; M J Davies
Journal:  Diabetologia       Date:  2011-06-03       Impact factor: 10.122

2.  End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry.

Authors:  X L Yang; W Y So; A P S Kong; P Clarke; C S Ho; C W K Lam; M H L Ng; R R Lyu; D D Yin; C C Chow; C S Cockram; P C Y Tong; J C N Chan
Journal:  Diabetologia       Date:  2006-08-30       Impact factor: 10.122

3.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

Authors:  B R Hemmelgarn; Finlay A McAlister; Steven Grover; Martin G Myers; Donald W McKay; Peter Bolli; Carl Abbott; Ernesto L Schiffrin; George Honos; Ellen Burgess; Karen Mann; Thomas Wilson; Brian Penner; Guy Tremblay; Alain Milot; Arun Chockalingam; Rhian M Touyz; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

Review 4.  Statins and the prevention of stroke in diabetes.

Authors:  Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

Review 5.  The role of global risk assessment in hypertension therapy.

Authors:  S A Grover; Brenda Hemmelgarn; Lawrence Joseph; Alain Milot; Guy Tremblay
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

6.  Altered cerebral regulation in type 2 diabetic patients with cardiac autonomic neuropathy.

Authors:  H Marthol; C M Brown; U Zikeli; D Ziegler; N Dimitrov; R Baltadzhieva; M J Hilz
Journal:  Diabetologia       Date:  2006-08-29       Impact factor: 10.122

7.  Practical aspects of the control of cardiovascular risk in type 2 diabetes mellitus and the metabolic syndrome.

Authors:  Anca Cerghizan; Cornelia Bala; Cristina Nita; Nicolae Hancu
Journal:  Exp Clin Cardiol       Date:  2007

8.  Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.

Authors:  C M Parrinello; K Matsushita; M Woodward; L E Wagenknecht; J Coresh; E Selvin
Journal:  Diabetes Obes Metab       Date:  2016-06-14       Impact factor: 6.577

9.  Modifications of coronary risk factors.

Authors:  Jeanine Albu; Sheldon H Gottlieb; Phyllis August; Richard W Nesto; Trevor J Orchard
Journal:  Am J Cardiol       Date:  2006-04-19       Impact factor: 2.778

10.  Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians.

Authors:  Michel P Hermans; Jean-Charles Fruchart
Journal:  Ther Adv Chronic Dis       Date:  2011-09       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.